Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure

NCT02600234 is registered in ClinicalTrials.gov with Corvia Medical as lead sponsor.

NCT NCT02600234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Lead sponsor
Corvia Medical
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 31, 2015
Completion date
August 31, 2026
Enrollment
44 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure